JNJ4796 [CAS 2241664-16-2]
Partner: MedChemexpress LLC
| CAS No: | 2241664-16-2 |
| Applications: | COVID-19-anti-virus |
| MW: | 537.57 |
| Formula: | C28H27N9O3 |
| SMILES: | CC(NC1=CC=C(OC(C2=CC(C(N3CCN([C@@H](C4=NN(C)N=N4)C5=CC=CC=C5)CC3)=O)=NC=C2)=N6)C6=C1)=O |
| Purity: | 99.85 |
| Description: | JNJ4796 is an oral active fusion inhibitor of influenza virus, neutralizing influenza A group 1 viruses by inhibiting hemagglutinin (HA)-mediated fusion. JNJ4796 mimics the functionality of the broadly neutralizing antibodies (bnAbs)[1]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
